Microbot Medical Inc. (MBOT)

NASDAQ: MBOT · USD

$1.12

+0.08 (+8.3%)· Recorded snapshot

Market cap	74.9M
Revenue (ttm)	346K
Net income (ttm)	-16.3M
EPS (ttm)	-$0.26
Shares out	67.2M
Volume	1,841,128
Beta	1.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 346K
Net income (ttm): -16.3M
EPS (ttm): -$0.26
Market cap: 74.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-32.9

P25 n/aP50 n/aP75 n/a

ROIC-23.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MBOT indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000883975
Company name	Microbot Medical Inc.
Country	United States
Country code	US
CUSIP number	59503A204
Earnings date	2026-11-11
Earnings time	amc
Employees	43
Employees change	23
Employees growth	115%
Enterprise value	$8.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US59503A2042
Last 10-K release date	2026-03-26
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2018-09-05
Last stock split type	Reverse
Market cap	$74.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$1.12
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	MBOT
U.S. state	Massachusetts
Website	https://microbotmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-23.46%
EV/Sales	7.77x
FCF / EV yield	-666.82%
FCF yield	-25.92%
Forward EV/Sales	1.06x
Forward P/S	27.35x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	1x
P/S ratio	199.94x
Price / tangible book value	1x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-185.26%
Operating margin	-5,348.84%
Pretax margin	-4,722.25%
Profit per employee	$-379,977
Revenue per employee	$8,047
ROA	-21.72%
ROA (5Y)	-57.46%
ROCE	-26.64%
ROE	-32.91%
ROE (5Y)	-135.92%
ROIC	-23.06%
SBC / revenue	352.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	15
EPS growth years	3
Net income growth years	0
Revenue growth (QoQ)	129.52%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-288,000
Depreciation and amortization	$47,000
EBIT	$-18.5M
EBITDA	$-18.5M
EPS	$-0.26
FCF per share	$-0.27
Financing cash flow	$53.7M
Free cash flow	$-17.9M
Free cash flow minus SBC	$-19.1M
Gross profit	$-641,000
Investing cash flow	$-36.8M
Net cash flow	$-720,000
Net income	$-16.3M
Operating cash flow minus SBC	$-18.9M
Operating income	$-18.5M
Revenue	$346,000
Stock-based compensation	$1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	18.28
Book value per share	$1.03
Debt / equity	0.01
Long-term assets	$1.2M
Long-term liabilities	$550,000
Net cash (debt)	$66.5M
Net cash / market cap	96.11%
Net cash growth	104.43%
Net debt / equity	-0.96
Piotroski F-Score	1
Property, plant and equipment	$1.1M
Shareholders' equity	$68.9M
Tangible book value	$68.9M
Tangible book value per share	$1.03
Total assets	$73.4M
Total cash	$67.4M
Total debt	$876,000
Total liabilities	$4.4M
WACC	9.88%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	$72.2M
Current liabilities	$3.9M
Current ratio	18.56
Net working capital	$1.2M
Quick ratio	17.37
Working capital	$68.3M
Working capital turnover	0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-146.72%
Dividend yield	0%
Shareholder yield	-146.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.73
1D price change	8.25%
1M price change	-12.55%
1M total return	-12.55%
1W price change	18.6%
1W total return	18.6%
1Y price change	-53.35%
1Y return CAGR	-53.37%
1Y total return	-53.35%
20-day SMA	$1.03
200-day SMA	$1.86
3M price change	-35.92%
3M total return	-35.92%
3Y price change	-3.88%
3Y return CAGR	-1.31%
3Y total return	-3.88%
50-day SMA	$1.26
50-day SMA vs 200-day SMA	50under200
52-week high	$2.86
52-week high date	2026-03-11
52-week low	$0.93
52-week low date	2026-10-22
5Y price change	-84.41%
5Y return CAGR	-31.04%
5Y total return	-84.41%
6M price change	-48.62%
6M total return	-48.62%
All-time high	$192.03
All-time high date	2016-11-29
All-time low	$0.82
All-time low date	2024-09-05
Average true range (ATR)	$0.07
Average volume	841.9K
Beta (1Y)	1.64
Beta (2Y)	1.45
Beta (5Y)	1.05
Change from 52-week high	-60.95%
Change from 52-week low	19.89%
Change from all-time high	-99.42%
Change from all-time low	35.98%
Change from open	0.9%
Day's gap	7.28%
Dollar volume	$2.1M
High price	$1.14
Low price	$1.07
Monthly RSI	38.31
Open price	$1.11
Position in 52-week range	66.67%
Premarket change	7.77%
Premarket close	$1.03
Premarket price	$1.11
Premarket volume	250.7K
Previous close	$1.03
Price vs 150-day SMA	-35.62%
Price vs 20-day SMA	8.46%
Price vs 200-day SMA	-39.96%
Price vs 50-day SMA	-11.72%
Relative volume	2.2
RSI	51.72
Sharpe ratio	-0.83
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	0.11
Sortino ratio	-1.18
Sortino ratio (3Y)	0.78
Sortino ratio (5Y)	0.31
Volume	1.8M
Weekly RSI	34.96
YTD price change	-44.25%
YTD total return	-44.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67.2M
Float percentage	100%
Shares change (QoQ)	0.01%
Shares change (YoY)	146.72%
Shares held by institutions	17.52%
Shares outstanding	67.2M
Short % of float	8.92%
Short % of shares	8.92%
Short ratio	14 days

Deeper analysis on MBOT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MBOT report

Is a complete MBOT research report available?

No complete published report is available for Microbot Medical Inc. (MBOT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Microbot Medical Inc. (MBOT)

Price

Financial snapshot

Fair-value bridge

Latest news · MBOT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MBOT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MBOT

Frequently asked questions